Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical p
| Filed | Insider | Role | Shares | Value | |
|---|---|---|---|---|---|
| 2026-09-15 | Presidio Management Group XII, L.L.C. | 10%-owner | 200,000 | $3,000,000 | Form 4 |
from2028 — cross-site stock view. Rebuilt at publish time.